Cagrilintide
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Novo Nordisk · Phase 1 · Recruiting · Enrollment 114
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.